Inovio Pharmaceuticals Inc

Research Inovio Pharmaceuticals Inc (INO) on Bullrun: market cap USD 92.15M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 92.15M
• Financial periodFY2025
• RevenueUSD 65.34K
• Revenue growth-70.0%
• Net income-USD 85.00M
• Free cash flow-USD 88.92M

Valuation Snapshot

latest market cap is USD 92.15M.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids.

Frequently asked questions

What is Inovio Pharmaceuticals Inc's market cap?

Inovio Pharmaceuticals Inc's market capitalization is USD 92.15M.

What does Inovio Pharmaceuticals Inc do?

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.